<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate whether the reactive oxygen species (ROS) and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ATP-sensitive <z:chebi fb="120" ids="26216">potassium</z:chebi> (mitoKATP) channels were involved in delayed neuroprotection induced by <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) levels </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Eighty-four male SD rats weighing 250 approximately 280 g, undergoing thread embolism of the right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) to cause focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 2 h and then undergoing 24 h reperfusion, were randomly divided into 7 groups (n=12, each): a sham group(S), an <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion group (I/R), a <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning group (Sevo), a 2-mercaptopropionylglycine (ROS scavenger)+<z:chebi fb="0" ids="9130">sevoflurane</z:chebi> group (MPG+Sevo), a 5-hydroxydecanoate (a mitoK(ATP) blocker) + <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> group (5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>+Sevo), an MPG group, and a 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> group </plain></SENT>
<SENT sid="2" pm="."><plain>The protein level of TNF-alpha and IL-1beta in the cerebral issue was detected by enzyme linked immunosorbent assay (ELISA) and the expression of <z:chebi fb="2" ids="33699">mRNA</z:chebi> was measured by semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:mpath ids='MPATH_3'>Apoptosis</z:mpath> index (AI), the protein level and the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of TNF-alpha and IL-1beta were significantly higher in the I/R group than those of Group S </plain></SENT>
<SENT sid="4" pm="."><plain>Pre-administration of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> could inhibit the increase of the protein level and the expression of <z:chebi fb="2" ids="33699">mRNA</z:chebi> of TNF-alpha, and IL-1beta and attenuate the cerebral damage induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Neuroprotection of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning was abolished by MPG and 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>However, MPG and 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> alone had no effect </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> can produce delayed protection against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion injury by down-regulating TNF-alpha, IL-1beta protein, and <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
</text></document>